Compugen Ltd. (CGEN)

Compugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor Targets

Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference

Compugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor Targets

Compugen Ltd. (CGEN) Discusses COM701 in Ovarian Cancer, MAIA Trial Preview, and UNIGEN Platform Advancements Transcript

Compugen (NASDAQ:CGEN) versus MiMedx Group (NASDAQ:MDXG) Head-To-Head Comparison

Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026

Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference

All You Need to Know About Compugen (CGEN) Rating Upgrade to Buy

Are Medical Stocks Lagging Compugen (CGEN) This Year?

Compugen: Better Runway Ahead Of MAIA

Compugen Ltd. (CGEN) Q2 2026 Earnings Call Transcript

Compugen Q2 Earnings Call Highlights

Compugen (CGEN) Reports Q2 Loss, Misses Revenue Estimates

Compugen Reports Second Quarter 2026 Results

Compugen to Participate in BTIG Biotechnology Conference 2026

Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026